Evidence map›Paper›PMID 22617822›Full record

ReviewCurrent opinion in rheumatology2012

Role of Helicobacter pylori infection in autoimmune diseases.

Sarfaraz Ahmed Hasni

Abstract readReview
In one paragraph

Review in Current opinion in rheumatology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 79 citations in OpenAlex.

  1. Helicobacter pylori infection and risk of multiple sclerosis: an updated meta-analysis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2024
    Pooled it
  2. Pooled it
  3. Trial
  4. Clinical Pathologic Profiles ofJournal of clinical medicine · 2025
    Article
  5. Article
  6. Review
  7. Epidemiology and infection · 2020
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Unmet needs in autoimmunity and potential new tools.Clinical reviews in allergy & immunology · 2014
    Review
  14. Review
  15. Review
  16. Helicobacter pylori and Systemic Disease.Gastroenterology research and practice · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Sarfaraz Ahmed HasniNational Institute of Arthritis, Musculoskeletal and Skin Diseases, Bethesda, Maryland, USA. hasnisa@mail.nih.gov
National Institute of Arthritis and Musculoskeletal and Skin Diseases · US

Funding

Clinical Training in RheumatologyZIEAR041176 · NIAMS · NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES · PI COLBERT, ROBERT · 2009 to 2025
$29.8M
Intramural NIH HHS Z99 AA999999Intramural NIH HHS Z99 AR999999Intramural NIH HHS Z99 DA999999
6 · The paper itself

Abstract

purpose of reviewThe etiology of most autoimmune diseases remains elusive. Prevailing evidence suggests an environmental trigger in a genetically susceptible individual. Helicobacter pylori (H. pylori) have managed to survive in a hostile environment in their host for long period and have evaded eradication by the immune system. Its chronic interaction with the immune system and the ubiquitous presence worldwide makes H. pylori an ideal candidate to study as a trigger of autoimmune phenomena. In this review, we would present data regarding the interplay between H. pylori and various components of the immune system and its association with various autoimmune diseases. RECENT

findingsStrong associations of H. pylori with some autoimmune diseases such as immune thrombocytopenia have been found; but most other autoimmune disease studies have revealed conflicting data. The chronic survival of H. pylori in humans is possible because of an overall downregulation of the body's immune response. In addition to this overall effect on the immune system, there are clinical and epidemiological data suggestive of H. pylori infection having a protective role in some autoimmune diseases. SUMMARY: Based on our review H. pylori status should be checked and treated only in certain autoimmune diseases such as ITP. For the majority of the autoimmune diseases, the role of H. pylori remains controversial signifying need for further research.

Indexed as

Helicobacter pyloriAutoimmune DiseasesHelicobacter InfectionsHumansImmunity, InnatePurpura, Thrombocytopenic, Idiopathic

Identifiers

PMID22617822
PMCPMC3643302
OpenAlexW1992022935

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.